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Abstract
Small G-proteins of the superfamily Ras function as molecular switches, interacting with different cellular partners according
to their activation state. G-protein activation involves the dissociation of bound GDP and its replacement by GTP, in an
exchange reaction that is accelerated and regulated in the cell by guanine-nucleotide exchange factors (GEFs). Large
conformational changes accompany the exchange reaction, and our understanding of the mechanism is correspondingly
incomplete. However, much knowledge has been derived from structural studies of blocked or inactive mutant GEFs, which
presumably closely represent intermediates in the exchange reaction and yet which are by design incompetent for carrying
out the nucleotide exchange reaction. In this study we have used comparative modelling to recreate an exchange-
competent form of a late, pre-GDP-ejection intermediate species in Arf1, a well-characterized small G-protein. We
extensively characterized three distinct models of this intermediate using molecular dynamics simulations, allowing us to
address ambiguities related to the mutant structural studies. We observed in particular the unfavorable nature of Mg2z
associated forms of the complex and the establishment of closer Arf1-GEF contacts in its absence. The results of this study
shed light on GEF-mediated activation of this small G protein and on predicting the fate of the Mg ion at a critical point in
the exchange reaction. The structural models themselves furnish additional targets for interfacial inhibitor design, a
promising direction for exploring potentially druggable targets with high biological specificity.
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Introduction
Small G-proteins of the Ras superfamily [1] are single-subunit
proteins functioning as molecular switches. They can be
maintained in an activated or deactivated state according to the
presence of bound GTP or GDP, respectively [2]. While
deactivation occurs by regulated hydrolysis of the GTP phospho-
diester bond, activation requires dissociation of the resulting GDP
molecule, followed by binding of a new GTP. Spontaneous GDP
dissociation is slow (on the order of hours [3]), so nucleotide
exchange in the cell is accelerated and regulated by guanine-
nucleotide exchange factors, or GEFs. The GEF binds to the
inactive G-protein-GDP complex and facilitates expulsion of the
GDP. Understanding this reaction in detail is the goal of much
current research. Several human diseases involve G-protein up
regulation [4]. Specific inhibition of GEF action has thus attracted
significant attention, with the G-protein-GEF interface itself as a
potential therapeutic target [3,5–8].
The Arf family of small G proteins are involved in vesicular
protein trafficking within the cell. They were discovered as a
consequence of their role in cholera infection [9], and have since
been implicated in several human disease processes including HIV
infectivity [10], pathogenic bacterial infection [11], and breast
cancer proliferation [12]. Arf GEFs are characterized by their
Sec7 domain in which the catalytic activity resides [13]. In the
multiple alignment of 52 Sec7-domain proteins, Cox et al. [14]
observed a high correspondence between known Sec7 structural
features and alignment breakpoints, suggesting that the principal
structure-function determinants are shared throughout the entire
Sec7 family of GEFs. Indeed, Arf-GEFs from yeast can be used to
catalyze nucleotide exchange in human Arfs [15]. Arf1 in
particular has yielded particularly rich structural information in
the form of crystal-structures obtained along the nucleotide
exchange reaction pathway. These include the GDP-bound and
GTP-bound Arf1 endpoints, free Sec7 domains, and several
intermediates in which the Arf1-GEF complex was captured at
different points in the exchange reaction by either point mutation
or judiciously chosen conditions [6,15–19]. These structural
snapshots have furnished unprecedented insight into the overall
steps involved in the exchange reaction.
GEF-promoted nucleotide exchange involves protein-protein
complex formation with large structural rearrangements. The first
half of the exchange reaction, i.e., up to the dissociation of GDP,
can be written schematically:
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The intermediates indicated in this scheme are presumed to be
closely represented by crystal structures, as summarized in Renault
et al (2003) [6], which reveal several important conformational
changes in the G-protein and the GEF. The initial binding of the
GEF to inactive Arf1-Mg2z-GDP is accompanied by closure of
the exchange factor hydrophobic groove separating the N- and C-
terminal subdomains [6,19] and is accompanied by extraction of
the beta strand of switch 1 from its pairing with the so-called
‘‘interswitch toggle’’, resulting in intermediate I. The two partner
proteins then associate more closely, accompanied by a shift of the
interswitch along its axis, which blocks intramolecular binding of
the myristoylated N-terminal helix and leads to intermediate II.
This conformation favors membrane association of the complex
and frees up space to accommodate the eventual Pc of the GTP
[6]. Actual GDP dissociation is accomplished between intermedi-
ate forms II and III, the latter represented by the nucleotide-free
intermediate resolved by Goldberg [15]. In this structure, at the
midpoint of the exchange reaction, the interface with the GEF is
more extensive and the P-loop has been transformed into another
turn of the Arf1 helix 1.
While the crystal structure data provide a uniquely detailed view
of the Sec7-mediated exchange reaction, fundamental mechanistic
questions remain unanswered. For example, in GDP ejection it is
presumed that a conserved Glutamate residue in the GEF acts on
the phosphate moiety of the GDP by electrostatic repulsion, but
details of this mechanism have not yet been obtained. Also, in
most small G-proteins, some of the GDP binding energy comes
from Mg2z, which at high concentration has been shown to have
an inhibitory effect on GDP-GTP exchange [20]. Molecular
dynamics simulations of GDP-bound but Mg-free G-proteins [21]
led those authors to suggest that Mg2z dissociation should occur
in order for the GEF to bind. Yet crystal structures [6,19] of the
earliest available intermediate structure in the Arf system, that of
the small-ligand BFA-inhibited Arf1-GDP-BFA-GEF complex,
indicate that Mg2z is still present. Thus Mg2z dissociation is not a
prerequisite for initial GEF binding, and indeed its presence may
be required [22]. The question of whether Mg2z dissociation
precedes GDP ejection remains open even after the structural
resolution [6] of the complex formed between Arf1-GDP and the
dominant-lethal GEF mutant E156K first identified by Beraud-
Dufour et al. (1998) [23]. There is no sign of the Mg ion in this
structure, which is consistent with the experimental observation
that high [Mg2z] inhibits the formation of the mutant complex
[23]. However, the positively-charged Lys sidechain, which
replaces the catalytic Glu residue in this mutant, partially occludes
the Mg2z binding site near the diphosphates [6]. It is thus not
possible to say whether the absence of Mg2z in this structure is an
artifact of the inactivating Lysine substitution or if Mg2z
dissociation naturally occurs at this stage.
The heart of the nucleotide exchange reaction lies in the passage
from intermediate II to intermediate III, during which GDP
expulsion occurs. Yet as just mentioned our understanding of the
pre-ejection intermediate species II is incomplete, being derived
from an inactive mutant protein. This situation is not uncommon–
intermediate species in a chemical or biological reaction are
intrinsically difficult to study experimentally due to their low
population and transience. This is where molecular modelling and
simulations provide complementary tools for exploring the
structural and dynamic properties of proteins and other biological
macromolecules. Indeed, each distinct crystal structure in the Arf
system offers a potential departure point for theoretical studies of
the conformational dynamics of the corresponding complex in the
vicinity of the reaction pathway. In the present study we have used
molecular modelling to recreate a native-sequence, exchange-
competent form of the late, pre-GDP-ejection intermediate II,
based on the structure of the inactive mutant complex. We have
extensively characterized three models of this intermediate using
molecular dynamics simulations, shedding light in particular on
Arf1-GEF interactions and the fate of the Mg ion in the exchange
reaction. These results open the door to mechanistic studies of
nucleotide ejection, at the heart of small G-protein activation. The
structural models themselves furnish additional targets for
interfacial inhibitor design [7], which has emerged as a promising
direction for exploring potentially druggable targets with high
biological specificity.
Results
The guanine-nucleotide exchange reaction, like all reactions
involving macromolecules, takes place in a conformational space
of very high dimension. While the actual path taken by a
particular G-protein-GEF complex through this enormous space
cannot be predicted, it is likely that a common, more restrained
region of the conformational space will envelope most such paths,
particularly near the transition state. The structures of known G-
protein-GEF complexes each constitute a point in this space, lying
in or near this reaction path region. However, experimental
structure determination frequently necessitates the use of devices
such as modified substrates, inhibitors or inactivating mutants in
order to trap intermediate structures. Such devices can introduce
ambiguity in interpretions of the structural results, as a resulting
complex may not lie sufficiently close to the reaction pathway to
permit accurate mechanistic conclusions to be drawn.
To better understand GEF-mediated GDP dissociation, we used
computational approaches to recreate a putative on-pathway Arf1-
GDP-GEF species immediately preceding nucleotide ejection,
indicated in the schema above as intermediate II. This complex
was modelled on the structure of the abortive intermediate
complex 1r8s of Renault et al [6], itself obtained by an inactivating
GEF mutation E156K, by here reversing the mutated residue to
the original ‘‘catalytic’’ Glu. In recreating this active complex, we
had to confront the intrinsic ambiguity related to the absence of
Mg2z in the (inactive) 1r8s structure carrying the charge-reversal
mutation. The first major possibility is that Mg2z dissociated at a
previous step, although necessarily after the formation of the initial
complex I represented by the Arf-GDP-Mg2z-BFA-GEF complex
(1s9d), in which this ion is present [6]. We refer to the resulting
model for intermediate II as complex IIo, in which the ‘‘o’’
indicates the absence of Mg2z. A second possibility is that the ion
may have simply been displaced artefactually by the positively-
charged amino group of the mutant lysine residue, in which case
the Mg2z must be re-introduced into the model structure of the
native complex. Indeed, an example of this line of reasoning is
evident from the inclusion of Mg2z in Figure 4 of the article by
Renault et al. [6]. In the current study, two flavors of the putative
Mg2z-containing complex were considered. In the first, IIm1, the
Mg ion was placed in the ‘‘canonical’’ position seen in inactive
Arf1-GDP, in which coordination was made only with oxygen
from the beta phosphate. An alternative placement, in the
complex denoted IIm2, corresponds to the position of the
sidechain amino group of the mutant Lys (see Methods). This
placement allowed coordination by oxygen atoms from both alpha
and beta phosphates. Such a coordination geometry has been
Arf1 Activation Intermediate
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ADP-Mg2z interactions [24].
These three alternative models for the Arf1-GDP-GEF species
II are represented schematically in Figure 1 and are summarized
here:
N IIo: No Mg present
N IIm1: Mg2z bound in the ‘‘canonical’’ position
N IIm2: Mg2z bound in the vicinity of the positively-charged
sidechain amino group of the mutant Lys
Each of these reconstructed intermediate complexes was created
using comparative modelling and characterized using molecular
dynamics simulations.
Conformational Stability of Reconstructed Intermediates
For each model, two MD runs were performed for a total of
30 ns of simulation time. The overall behavior of the different
Arf1-GDP-GEF complexes was stable on the timescales of the
simulations. This was seen by the Ca rms distance of the protein
from the starting structure after best-fit superposition as a function
of time, which was seen in all runs to stabilize after about 500 ps
during the 1 ns equilibration period. Nevertheless, the conforma-
tional variation of the Arf1-GDP-GEF complexes differed
significantly for the three different models, as summarized in the
first column of Table 1. The Mg-free complex (IIo) showed the
least deviation from the starting structure, with an rmsd of 1.15 A,
while the values for the Mg2z-containing structures IIm1 and
IIm2 were larger by 0.2 to 0.4 A, respectively, with correspond-
ingly higher standard deviations.
Calculating the rmsd after best-fit superimposition of the
complex as a whole can mask deviations arising from domain
and subdomain movements or fluctuations at a smaller scale. For
this reason we also calculated the rmsd after superimposing the
complex in different ways. Superimposing the complex on the
separate components revealed each protein to be quite stable
individually, as seen by the two central columns in Table 1.
However, the rmsd statistics collected for Arno after superimpos-
ing on Arf1 showed much larger deviations, as seen in the last
column of this Table. This value indicates the magnitude of
orientational fluctuations of the two protein components with
respect to each other in the complex. We note that, regardless of
the superposition criteria employed, each of the measurements
shown in Table 1 suggest the Mg2z-free form to be the most stable
of the three models of intermediate II in terms of conformational
variability.
Mg2z Interaction
In model species IIm1, the Mg ion proved to be well localized,
with an rms fluctuation of 0.42 A in the coordinate system of the
GDP, which is essentially identical to that seen in the reference
Arf1-GDP simulation and in Ras MD studies [25]. In species IIm2
the Mg2z was far more mobile, with an rms fluctuation of 0.84 A
(Figure 2). The Mg ion in this model is more closely associated
with the sidechain of GEF residue Glu156, which as mentioned
above is more mobile than in IIm1.
Limited positional fluctuations do not necessarily reflect a strong
interaction between Mg2z and Arf1. In Arf1-GDP alone, the
energy of interaction measured between Arf1 and Mg2z (Figure 3)
was strongly negative; while in the intermediate complexes the
interaction became somewhat (IIm2) or substantially (IIm1)
positive. Two factors contribute to this effect. First, in the inactive
Arf1-GDP complex, Arf1 residues Glu54 and Asp67 interact
closely (carboxylate distances of 3.7 and 4.6 A, respectively) with
the Mg2z. In the transformation to intermediate II, the so-called
‘‘interswitch’’ beta-hairpin containing both residues is displaced
[6], as reflected in Figure 2, which modifies the respective
distances to at least 16.0 and 3.8 A and thus removing a source of
Arf1’s electrostatic stabilization of the Mg2z. Second, in the
inactive complex Arf1-GDP, the Mg2z interacts with Arf residue
Thr31 and with one of the GDP beta phosphate oxygens [26].
The Thr31OG-Mg distance remains on the order of 2.3 A in the
inactive Arf1-GDP complex and in intermediate I of the exchange
reaction. In both models IIm1 and IIm2, this interaction is
modified. In IIm2, the interaction is lost due to the initial Mg ion
placement in this system. In IIm1, in which the Mg2z was initially
placed in the position seen in the inactive Arf1-GDP complex, as
Figure 1. Mg2z placement for the three starting models of the
Arf1-GDP-GEF complex.
doi:10.1371/journal.pone.0009142.g001
Table 1. Conformational stability a of intermediate Arf1-GDP-
GEF complexes.
System Complex b Arf1 b Arno b Arno c
IIo 1.15 + 0.11 1.04 + 0.13 0.95 + 0.10 1.77 + 0.35
IIm1 1.33 + 0.13 1.21 + 0.17 1.03 + 0.12 2.05 + 0.44
IIm2 1.55 + 0.17 1.22 + 0.14 1.23 + 0.18 2.77 + 0.63
a rmsd,i nA.
b after C a superposition of the indicated species.
c after C a superposition on Arf1.
doi:10.1371/journal.pone.0009142.t001
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IIm2). Arf1 is shown in white. In the right panel the GEF is shown in light blue together with catalytic residue 156. Region of Mg2z localization is
shown as a transparent green surface.
doi:10.1371/journal.pone.0009142.g002
Figure 3. Energy of interaction between Arf1 and Mg2z. Interaction energy between Arf1 and Mg2z in the molecular dynamics simulations for
the Mg2z-containing model complexes IIm1 and IIm2 (top and middle sets of lines, respectively) and for the reference Arf1-GDP-Mg2z system (1hur)
seen at bottom, presented as a function of simulation time.
doi:10.1371/journal.pone.0009142.g003
Arf1 Activation Intermediate
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increase to 3.1 A as the Mg2z drew closer to the second beta-
phosphate oxygen during the equilibration period. The ion thus
gained electrostatic interaction with the GDP at the expense of its
interaction with Arf1. The motor for this modification appears to be
theapproachoftheGEF.Inparticular,the N-terminalofGEFhelix
7, which could contribute via a helix dipole effect, is much closer to
the Mg2z binding site (5 A) in intermediate II than in intermediate
I (12 A) due to the maturing of the Arf1-GEF interface. Indeed,
GEF residue Gln158 alone, at the N-terminal of this helix, was seen
to add +5 kcal/mol to the interaction energy with the Mg2z.
The interaction energies given in Figure 3 must be interpreted
with care: the standard molecular dynamics protocol used here
does not reflect atom polarizability [27,28]. Limitations of the
present calculations are discussed separately (see Discussion).
Nevertheless, the change of sign in the interaction energy for both
models suggests marked weakening of the Arf1 interaction with
Mg2z in intermediate species II.
Arf1-GEF and GDP-GEF Interactions
The surface buried in the Arf1-GEF interface was followed
throughout the simulations in order to identify potential
modifications of the protein-protein interface. The results for the
three models are presented in the first column of Table 2. The
area of the Arf1-GEF interface for the three models was more than
3000 A2, and falls in the range characterizing large biological
interfaces [29]. A dominant contribution to this interface area is
the burial of switch1 in the GEF hydrophobic groove. The
interface was seen to be larger by more than 200 A2 in the absence
of Mg2z than in its presence. The more extensive interface is
consistent with the analysis of the conformational fluctuations
of the Arf1-GEF complexes presented above, with the larger
interface associated with the ‘‘tighter’’, or less fluctuating, complex.
As would be expected for such interfaces, the measured energy
of interaction (van der Waals and electrostatic terms) between Arf1
and the GEF is large and negative (Table 2). The proportionality
of the energy of interaction and interface area is not expected to be
exact; however the interaction energy was seen to be significantly
more negative in the Mg2z-free form of the intermediate complex
II than in the other forms with lesser interface areas.
In addition to the improved protein-protein interaction energy,
the GEF also shows significantly stronger interaction with the GDP
in the absence of Mg than in its presence– in the latter case the
interaction energy is positive (Table 2). A significant component of
the improved interaction in the absence of Mg2z is electrostatic in
nature. Figure 4 shows the GDP binding region in representative
structures of the three different complexes IIo, IIm1, and IIm2
having the closest correspondence (1.1 A all-atom rmsd) to the
ensemble average in each case. The three structures demonstrate
significant differences in terms of the proximity of GEF N-terminal
subdomain residues to the GDP. The basic residues Lys 159 and
Arg 118 can be seen to approach the GDP more closely in the
Mg2z-free model IIo compared to IIm1 and IIm2. On the other
hand, the catalytic residue Glu156 is more distorted in the absence
of Mg2z, reflecting electrostatic repulsion by the GDP. We
calculated the contributions of the protein and GDP to the
electrostatic potential for the three models, focusing on the region
Table 2. Interface area and interaction energies.
System Interface a E
b
inter E
b
inter
Arf1-Arno Arno-GDP
IIo 3278 + 100 2368 + 31 222 + 10
IIm1 3070 + 126 2327 + 49 22 + 6
IIm2 3034 + 106 2349 + 31 13 + 7
a interface area in A2.
b interaction energy in kcal/mol.
doi:10.1371/journal.pone.0009142.t002
Figure 4. Representative structures for each of the three models of the Arf1-GDP-GEF complex. Shown are sampled MD structures
closest in an all-atom rmsd sense (v1:1 A in all cases) to the ensemble average for each of the three models of the Arf1-GDP-GEF complex. A: the
Mg2z-free complex IIo, B: complex IIm1 containing Mg2z, C: complex IIm2 containing Mg2z in an alternative position. Arf1 is colored rose, the GEF
light blue. In each panel GEF residues Glu156, Lys159, and Arg118 are shown. The Mg ion, when present, is indicated by a green sphere. Lines indicate
distances from phosphate oxygens to Lys159 and Arg118 when less than 8 A. Distances are 7.1 and 6.4 A, respectively, in IIo (A), 7.3 and 9.8 A in
species IIm1 (B), and 9.2 and 8.3 A in species IIm2 (C). The corresponding averaged distances for the three systems are 7.4 and 7.6 A for IIo, 7.6 and
9.7 A for IIm1, and 8.6 and 9.9 A for IIm2.
doi:10.1371/journal.pone.0009142.g004
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closer approach of positively-charged GEF residues can be seen to
lead to a marked augmentation in the positive potential (in blue) at
the Arf1-GEF interface near the GDP phosphates. This is consistent
with the more favorable GDP-GEF interaction seen in the energy
calculations and the electrostatic destabilization of the Mg2z
binding site.
Free Energy Calculations
The differences in interaction energy seen between different
models of the pre-dissociation intermediate suggest differences in
the GEF and Mg2z binding affinities. However, binding affinities
are a function not only of the interaction energy between partners
in the complex but also of the solvation energy compared to the
unbound states. In order to estimate free-energy changes for the
formation of the different model complexes we used an MM-PBSA
approach [25,30,31].
Table 3 shows the MM-PBSA results for GEF binding to Arf1-
GDP, calculated over 100 snapshots (every 40 ps) of the
production MD for the three models of the pre-GDP-dissociation
complex (intermediate II). Free-energy changes are given along
with the components of the solvation free energy change, DEelec
(e~1) and DGnp, and the interaction energy term DEvdW. Values
of DEelec obtained using a protein dielectric constant of 4 are also
presented. Calculations performed using two different sets of radii
for the Poisson-Boltzmann analyses (see Methods) showed
insignificant differences in the final values, so only those obtained
using the Charmm radii are reported.
The affinity estimates can be interpreted in light of the following
schema, which shows the GDP, Mg2z, and GEF binding reactions
of Arf1:
DGm
Arf1 ? Arf1-GDP ? Arf1-GDP-Mg
;; DGa ;DGb
Arf1-GEF ? Arf1-GDP-GEF ? Arf1-GDP-Mg-GEF
DG’m
III IIo IIm1 or IIm2
The MM-PBSA calculations correspond to the indicated
vertical legs of this schema: DGa, representing GEF binding to
form the Mg2z-free complex IIo, and DGb, for GEF binding to
create either IIm1 or IIm2 containing Mg2z. The resulting
thermodynamic cycle allows one to express the free energy of
Mg2z binding to the Arf1-GDP-GEF complex as
Figure 5. Electrostatic potential differences between intermediate Arf1-GDP-GEF complexes. Arf1 at top and the GEF at bottom. As in
the previous Figure, the complex shown at left is rotated by 90 deg about the vertical axis such that the GDP (with phosphates shown in space-filling
representation) is facing the viewer. Difference electrostatic potential isosurfaces are shown for the intermediates IIo–IIm2, showing the increased
positive potential in the interface region in species IIo. The potential grid for each species was obtained using focusing on the restrained cubic
volume shown, centered on atom O3’ of the GDP with a grid step of 0.25 A. Only protein and GDP atoms were retained in each calculation for
consistency. The Dw~z1 kcal/mol :e is shown in blue, {1 kcal/mol :e in red, the latter rendered here as a transparent surface.
doi:10.1371/journal.pone.0009142.g005
Arf1 Activation Intermediate
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The strength of Mg2z binding to the complex is thus seen to be
obtained indirectly from the difference in GEF binding to the Mg-
free and the Mg2z-containing forms, in an example of a linkage
relation [32]. In contrast to the directly-measured Mg2z
interaction energies shown earlier, the values presented in
Table 3 should not be strongly dependent on the Mg2z
parameterization or polarizability, as they are calculated by
measuring differences in protein-protein binding affinities, and not
Mg2z or GDP binding directly.
Comparing the distributions of calculated free-energy changes
indicated that the Mg-free Arf1-GDP-GEF complex IIo is
significantly (Student’s t-test, p=0.0001) more stable than the
Mg2z-containing complexes IIm1 and IIm2, confirming the
reasoning based on the interaction energy and buried surface
differences provided above. Application of the linkage relation
shows that the Mg2z binding affinity is greatly reduced in
intermediate complexes IIm1 and IIm2, with the association free
energy increasing by 25 kcal/mol and 49 kcal/mol, respectively.
The effect of including limited intrinsic protein flexibility on the
electrostatic energy differences, by varying the protein dielectric
from 1 to 4, reduced the overall unfavorable contribution of DEelec
to GEF binding (Table 3) but did not change the ranking of the
different modelled species. Indeed, for each term in Table 3,
species IIo is favored over the two Mg2z-containing species,
meaning that the ranking of the GEF affinities for the different
species is also independent of changes in the proportionality
constant c in equation 2 (see Methods).
Discussion
The small G protein Arf1 has yielded extensive biochemical and
crystal structure information and provides an exceptional model
for understanding GEF-catalyzed nucleotide exchange in detail.
Since the discovery of the Sec7-domain family of GEFs, different
mechanisms for the enhancement of nucleotide exchange have
been proposed. One of the first suggested that the GEF bound the
myristoyl group of Arf directly [33], supposing that accompanying
structural changes would result in release of the nucleotide. A
subsequent suggestion that closure of the hydrophobic groove
produced GDP expulsion [18] was itself later seen to be
inconsistent, first with our own normal mode calculations [34]
and then more directly with the crystal structures of the BFA-
blocked complex (intermediate I) in which the hydrophobic groove
was closed but the nucleotide remained in place [6,19]. This
blocked complex has been exploited successfully as a target for
structure-based discovery of a new inhibitor of Arf activation [8],
highlighting the interest of identifying and structurally character-
izing reaction intermediates in drug design.
One point of agreement in mechanistic studies of small G
proteins is the importance of destabilizing the GDP in its binding
site. Nevertheless, beyond sequestering the Arf1 beta strand 40–50
in the hydrophobic groove of the GEF, a clearly necessary but not
sufficient step, it is still not clear how this destabilization takes
place. Knowledge of the fate of the Mg2z is essential, as the
mechanistic consequences of its absence or presence will be clearly
quite different for the subsequent steps resulting in GDP
dissociation. Even in the absence of the GEF, removal of Mg2z
(by addition of EDTA) accelerates nucleotide exchange by a factor
of about 20, although this is small compared to the factor of
20,000 due to normal GEF action [23]. Simulation studies of
GDP-bound small G proteins, including Arf1, both with and
without Mg2z [21], suggested structural consequences that could
help explain the necessity for removing this ion in order to
destabilize the G-protein-GDP complex. But studies of the early
intermediate (I) captured by inhibition with the small molecule by
Brefeldin A (BFA), showed the Mg2z to remain bound to the GDP
[6,19]. Thus the initial interaction of the GEF with Arf1-GDP
does not in itself result in Mg unbinding. This led to the suggestion
[19] that the GEF ejected both GDP and the Mg2z in the next
step of the reaction.
TheMDsimulationsandfree-energycalculationspresentedhere,
performed with native-sequence, exchange-competent components,
suggest that intermediate II in the nucleotide exchange reaction is
best represented by the Mg-free model IIo of the Arf1-GDP-GEF
complex. The Mg2z-free complex presented a significantly larger
protein-protein interface than the Mg2z-containing versions. The
presence of Mg2z, in two alternative placements, prevented the
basic residues from the GEF N-terminal subdomain from
approaching the GDP binding site as close as they could in the
Mg-free complex. The formation of close Arf1-GEF interactions in
passing from intermediate I to II would thus play a dual role, first in
promoting the rearrangement of the interswitch in Arf1 and,
second, in promoting dissociation of the Mg2z. Our theoretical
results on Mg2z destabilization are consistent with an NMR study
[22] that suggested that both Arno mutants E156K and E156A
result in abortive Arf1-GDP-GEF complexes accompanied by
Mg2z release. Taken together, these results would indicate that the
Mg ion is displaced in passing from intermediate conformation I to
II in the exchange reaction, and thus that the Mg-free intermediate
II is the immediate precursor to GDP ejection. In the ‘‘Rho of
plants’’ system, the structure of a predissociation complex [35]
showed the Mg2z binding site to be occluded by an alanine residue
coming from the G-protein itself. Although this is clearly a different
mechanism from that suggested here for Arf1, those authors
suggested that the dissociation of Mg2z prior to GDP dissociation
may be necessary in all G-proteins. It must be cautioned, however,
that Mg2z destabilization by the GEF is still only one part of
the picture. In EF-Tu, for example, Mg2z removal increases
Table 3. MM-PBSA analyses of GEF binding
a.
System DG DEelec DEelec DGnp DEvdW
e~1 e~4
IIo 259.7 + 13.1 88.6 + 15.8 15.8 + 3.5 214.9 + 0.6 2133.5 + 7.0
IIm1 211.0 + 34.2 130.2 + 36.2 27.6 + 8.2 214.4 + 0.7 2126.8 + 7.5
IIm2 234.6 + 20.1 91.9 + 19.7 16.8 + 4.7 214.3 + 0.6 2112.1 + 8.1
a all values given in kcal/mol.
doi:10.1371/journal.pone.0009142.t003
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nucleotide dissociation from the EF-Tu-Ts complex is only twofold
[36,37].
In our results, the Mg ion has a clear destabilizing effect on the
intermediate II complex and interacts less well than in the inactive
Arf1-GDP alone. This presumably results from the mutual
repulsion by the divalent Mg ion and several positively charged
GEF residues, which, along with the N-terminal of the GEF helix
7, cannot approach their stable positions in the Arf1-GDP-GEF
interface. It would be reasonable to conclude that the approach of
these positively charged GEF residues to the GDP helps ‘‘pay’’ for
the electrostatic repulsion between the GEF Glu156 and the GDP
phosphates, and that the presence of the Mg2z both prevents the
approach of this subdomain and annuls the repulsive interaction
between the two negatively-charged moieties. In the succeeding
steps of the exchange reaction, the approach of GTP-Mg2z would
then act to reverse these effects, promoting the breakdown of the
close interactions between Arf1 and the GEF in the nucleotide-free
intermediate II.
The structure of the mutationally inactived Arf-GDP-GEF
complex 1r8s [6] is the closest pre-GDP-dissociation complex to
the nucleotide-free intermediate [15] yet obtained. Nevertheless,
the exact nature of the native species approximated by this crystal
structure has so far remained unclear. As we have described here,
in silico re-integration of the catalytic glutamic finger to create a
three-dimensional model of the corresponding native-sequence–
and thus exchange-competent–intermediate enabled us to eluci-
date several important aspects of the critical steps involved in GDP
ejection. The recreated intermediate II provides a self-consistent
departure point for more detailed mechanistic studies of the GEF-
assisted exchange reaction, using theoretical methods appropriate
for the study of reaction paths (e.g., reference [38]). Further, the
Mg2z-free intermediate II species provides a new pharmaceutical
target for potentially modulating Arf1 up-regulation at a critical
point in the activation pathway.
Limitations of the Current Study
As in any modelling and simulation study, certain approxima-
tions were necessary in this work. The intermediate species were
modelled on the known structure of an inactive intermediate
complex. We note that this reconstruction step, involving the
modification of a single protein residue, is much milder than that
used successfully in other comparative modelling studies, where
sequence identity is often in the range of 40–50%. The fixed-
charge representation used in the present study is currently the
most commonly used MD methodology. However, it is not as
realistic as more computationally expensive approaches including
effects of atom polarization, which are not yet widely employed in
macromolecular simulations. Expected differences from the
inclusion of polarization would include reduction in the magni-
tudes of the calculated protein-Mg2z interaction energies shown
in Figure 3 for all three systems, as the Mg2z formal charge would
be partially compensated by polarization of nearby atoms [39,40].
On the other hand, the qualitative destabilization of the Mg2z by
the GEF seen in the same Figure would be unlikely to be modified
by the inclusion of polarizability. In a related vein, and as
discussed in a recent study of the Mg2z-containing EF-Tu system
which also employed a fixed-charge parameterization and the
Charmm force field [41], there are few highly polarizable protein
atoms in the vicinity of the Mg2z. The inclusion of polarization is
thus unlikely to significantly affect the indirect measure of Mg2z
binding from differences in protein-protein binding affinities
(Table 3, equation 2). Finally, an additional source of error arises
from potentially poorer sampling due to the inclusion of the
Mg2z. In a study of the double-helical 16S rRNA [42], the
inclusion of 24 Mg ions did show differences in detailed structural
properties of the nucleic acid when compared to a simulation
containing only monovalent ions, which were attributed to
sampling inadequacies. However, the overall collective motions
of the nucleic acid, as measured by the essential dynamics
(principal component analysis) of the macromolecular movements,
were very similar. The importance of such potential sampling
effects would be difficult to identify unambiguously without much
longer simulations.
Methods
Comparative Modelling
Studies were based on the pdb entry 1r8s of human Arf1 in
complex with a mutant of ARNO, its GEF, in the abortive
complex Arf1-GDP-ARNOE156K [6]. Corresponding studies of
the Arf1-GDP complex were based on the 1hur crystal structure
[26]. In the Arf1-GDP-ARNOE156K complex, the so-called
catalytic GEF (ARNO) residue Glu156 was modelled back into
the structure using Modeller [43], using 1r8s as template and
allowing modifications to residues within 5 A of the mutated
residues. One Mg-free and two Mg-containing models were
created. Two different Mg2z placements were studied: first at the
observed position in the Glu156-containing Arf1-GDP-BFA-GEF
intermediate 1s9d (after GDP superposition); second at the
coordinates of the Nf from the Lys substituting Glu156 in the
mutant GEF in the 1r8s crystal structure. In each case non-
obstructed water molecules around the ion position were brought
over along with the Mg2z from the corresponding crystal
structure. The model with the lowest objective function was
chosen for further study in each case.
Molecular Dynamics Simulations
The molecular simulation program Charmm [44] version 33,
using the param27 all-hydrogen parameter set and CMAP terms
[45], was used for molecular dynamics calculations and
subsequent analyses. Naz and Cl{ counterions, as well as
bound waters, were placed using Solvate [46]. Dynamics
trajectories (1 ns equilibration, 5 ns total for each trajectory,
30–40,000 atoms depending on the system) were run in the NPT
ensemble (1 atm, 300 K) using periodic boundary conditions and
rhombic dodecahedral geometry. Force shift electrostatics and a
nonbonded cutoff (12 A) were used in an approach that has
proved satisfactory in free-energy decomposition studies of the
Arf1-GDP-BFA-Arno complex [47] and other work [48]. As
verified by electrostatics calculations (see below), standard
ionization states were assigned to all protein residues, while the
GDP was assigned a total charge of 23, consistent with the
presence of the salt bridge with Lys30 of Arf1. For all models the
system was energy minimized using harmonic restraints on the
starting heavy atoms about their initial positions; the force
constant, initially set at 250 kcal/mol-A, was reduced in a
stepwise fashion during successive rounds of minimization until
its value fell below 10 kcal/mol-A, and was removed completely
before final minimization. Using SHAKE to constrain heavy-
atom-hydrogen covalent bonds and a different random seed for
each trajectory, the system was then heated to 300 K in 25
degree NVE dynamics steps, during which the stability of the
simulation was verified. This was followed by equilibration for
1 ns in the final NPT ensemble before the production phase.
Inital tests showed that the use of 1 or 2 fs integration timesteps
resulted in simulations of very similar stability, so the 2 fs value
was used for all reported runs.
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Free energy changes associated with Arf1-GEF association were
estimated by the MM-PBSA approach using snapshot structures
taken from the MD simulations of the complexes. In this method
the free-energy of each species is taken as the sum of the molecular
mechanics energy, a free energy change associated with the
transfer of the species to aqueous solution, and an entropy term.
For a given species the aqueous solvation contribution can be
broken down into the electrostatic work DGelec of charging the
species in continuum solvent with dielectric e~80, obtained here
by solution of the Poisson-Boltzmann equation, and a non-polar
surface solvation contribution DGnp which was estimated by a
surface tension, c, multiplied by the solvent accessible surface
ASASA. In the snapshot approach, which uses MD simulations of
the complex alone, the molecular mechanics term retains only the
van der Waals interaction terms between components, calculated
with no cutoff. For the reaction AzB?AB, the free-energy
difference is then
D
AB
A,BG~D
AB
A,BDGeleczcD
AB
A,BASASAzD
AB
A,BEvdW, ð2Þ
in which entropy terms are assumed to cancel as discussed in other
studies [47,49]. In the present study c~0:005 kcal/mol-A2 was
used [31]. Equation 2 was calculated for 100 MD snapshots
obtained at 40 ps intervals from the MD simulations of the Arf1-
GEF complex and averaged over each trajectory. Electrostatic
energies were calculated using the PBEQ-Solver procedure [50]
using an initial grid spacing of 1 A followed by focussing with a
grid step of 0.4 A, which was incorporated into an adaptation of
the binding energy protocol from the Roux group [thallium.bs-
d.uchicago.edu/RouxLab]. Electrostatic calculations were carried
out using either the Charmm atomic radii or a set of optimized
radii determined initially for proteins and augmented for nucleic
acids [51,52]; in the latter case an Mg2z radius of 1.55 A was
assigned. Calculations were performed with an ionic strength of
150 mM and protein dielectric constants of 1 or 4 as described in
the Results.
Electrostatics Calculations and pKa Determinations
The most probable ionization states in the complexes at pH 7
were verified using the approach of Antosiewicz et al. (1994) [53],
modified in order to allow the inclusion of an additional ionizable
phosphate oxygen, for which the model pKa of 6.4 in aqueous
solution was used [54]. Electrostatic analyses were made for
energy-minimized structures using UHBD [55] to solve the finite-
difference Poisson-Boltzmann equation on a cubic grid of length
110 using four-step electrostatic focussing with grid spacings
decreasing from 2 to 0.25 A. These calculations employed
Charmm atomic radii, an ionic strength of 150 mM, a smoothed
molecular surface dielectric-boundary with a 2 A Stern layer, and
protein/solvent dielectric constants of 20/80 [54]. Calculated
pKa’s were consistent with the standard ionization states at pH 7
in all cases, with the exception of the additional ionization center
at atom O2B of the GDP. For this group a pKa of 1.7 + 0.7 was
obtained, confirming its essentially complete ionization at pH 7
due to the salt bridge formed with Arf1-Lys30. The triply ionized
state of the GDP was thus used in all MD simulations.
All graphical molecular representations in this study were
generated using VMD [56].
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